Biocon stock reports 10.00 percent Q1 FY27 revenue growth

Published on 09/29/2026 at 16:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Biocon stock posted INR 43.36 billion in Q1 FY27 revenue, up 10.00 percent year over year. An analyst model lifted fair value to INR 446.89.

Biocon, INE376G01013, Illustration mit AI erstellt.

Biocon stock is anchored by Q1 FY27 revenue of INR 43.36 billion, up 10.00 percent from INR 39.42 billion a year earlier. The result gives the biosimilars specialist a measurable growth base as its latest market value stood at INR 515.4 billion on September 29, 2026.

Revenue growth reaches INR 43.36 billion

Screener lists consolidated June 2026 sales at INR 4,336 crore, compared with INR 3,942 crore in June 2025. That is a 10.00 percent year-over-year increase and makes revenue the clearest current operating comparison.

The same company overview shows June 2026 operating profit of INR 847 crore and net profit of INR 137 crore. Operating margin was 20.00 percent, while earnings per share was INR 0.87 for the quarter.

Biosimilars remain the core engine

Biocon is not a single-product story. According to Screener, biosimilars represented 60 percent of the business mix in fiscal year 2026, versus 58 percent in fiscal year 2025. Research services contributed 22 percent, while generics accounted for 18 percent in fiscal year 2026.

This mix matters because biosimilars provide the main growth narrative, while the quarterly figures show the pressure that can arise in a business with several operating divisions. The comparison between INR 43.36 billion of June 2026 sales and INR 45.17 billion in March 2026 also points to a 4.01 percent sequential decline, despite the year-over-year gain.

Fair value moves to INR 446.89

Yahoo Finance reported on September 20, 2026 that an analyst model raised Biocon fair value from INR 429.67 to INR 446.89. The increase was 4.01 percent, with the update tied to execution and earnings visibility.

Market value stays measurable

Biocon was last at INR 378.00 on the BSE on September 29, 2026 at 3:29 p.m. IST. Its 52-week range was INR 337.20 to INR 447.00, placing the quote INR 69.00 below the yearly high and INR 40.80 above the yearly low.